| Antimicrobial peptides: a new frontier in antifungal therapy G Buda De Cesare, SA Cristy, DA Garsin, MC Lorenz MBio 11 (6), 10.1128/mbio. 02123-20, 2020 | 166 | 2020 |
| Recent trends in molecular diagnostics of yeast infections: from PCR to NGS T Gabaldón FEMS microbiology reviews 43 (5), 517-547, 2019 | 109 | 2019 |
| Structural and functional analysis of EntV reveals a 12 amino acid fragment protective against fungal infections MCLDAG Melissa R. Cruz, Shane Cristy, Shantanu Guha, Giuseppe Buda De Cesare ... Nature Communications 13 (1), 2041-1723, 2022 | 21* | 2022 |
| Biomarkers of caspofungin resistance in Candida albicans isolates: A proteomic approach GB De Cesare, A Hafez, D Stead, C Llorens, CA Munro Virulence 13 (1), 1005-1018, 2022 | 13 | 2022 |
| Monoclonal Antibodies Targeting Surface-Exposed Epitopes of Candida albicans Cell Wall Proteins Confer In Vivo Protection in an Infection Model S Palliyil, M Mawer, SA Alawfi, L Fogg, TH Tan, GB De Cesare, LA Walker, ... Antimicrobial Agents and Chemotherapy 66 (4), e01957-21, 2022 | 9 | 2022 |
| The development of single-domain VHH nanobodies that target the Candida albicans cell surface G Buda De Cesare, FM Sauer, A Kolecka, AA Stavrou, TC Verrips, ... Microbiology spectrum 12 (11), e04269-23, 2024 | 5 | 2024 |
| Antimicrobial Peptides: A New Frontier in Antifungal Therapy. mBio 2020, 11 (6), e02123-20 G Buda De Cesare, SA Cristy, DA Garsin, MC Lorenz DOI 10, 02123-20, 0 | 5 | |
| Optimization of the antifungal properties of the bacterial peptide EntV by variant analysis S Guha, SA Cristy, G Buda De Cesare, MR Cruz, MC Lorenz, DA Garsin MBio 15 (5), e00570-24, 2024 | 3 | 2024 |
| Characterization of the mechanism of action of the Enterococcus faecalis bacteriocin EntV on Candida albicans G Buda De Cesare, Y Chebaro, S Guha, M Cruz, D Garsin, M Lorenz Access Microbiology 3 (12), po0153, 2021 | | 2021 |
